Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
24.80
+0.37 (1.51%)
At close: Apr 28, 2026, 4:00 PM EDT
24.80
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Agios Pharmaceuticals Employees
As of December 31, 2025, Agios Pharmaceuticals had 540 total employees, including 539 full-time and 1 part-time employees. The number of employees increased by 52 or 10.66% compared to the previous year.
Employees
540
Change (1Y)
52
Growth (1Y)
10.66%
Revenue / Employee
$100,052
Profits / Employee
-$764,409
Market Cap
1.45B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immatics | 711 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Maze Therapeutics | 141 |
AGIO News
- 22 days ago - Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET - GlobeNewsWire
- 4 weeks ago - PK Activation Gains Momentum in Thalassemia Agios' Aqvesme Launch Reflects Strong Promise with Deliberate Uptake - GlobeNewsWire
- 4 weeks ago - Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET - GlobeNewsWire